| Followers | 0 |
| Posts | 1357 |
| Boards Moderated | 0 |
| Alias Born | 03/20/2022 |
Saturday, October 22, 2022 3:16:23 AM
Just to be clear, im not at all suggesting this is whats actually happening.
When the "worst pr ever" was released, upon the first read i immediately knew it would trigger a selloff.....which ended up being proven 100% true.
It was made even worse when a more detailed explanation was much later provided to dales and this imo calmed many frayed nerves.
That instilled some suspicion since IMO there was no way anyone who read it wouldnt see that it was atrociously worded.....that thankfully was addressed in subsequent Prs.
Dont know about anyone else but witnessing the premarket bid/ask retreating to the 5c range was very disconcerting at first, that is until i began to view it as a potential buying opp.
All im now saying is bmt et al's concerns has once again raised my suspicions (unsubstantiated skepticism) about these missteps at this most critical of points in the process, nothing more nothing less.
I once again reiterate, his loyalty is to revive and probably to canaccord.....NOT LONGS.
Honestly speaking, why would he care if some longs get snookered into selling since there will be no shortage of investors immediately willing to snap them up.
The only event that will affect revive are the upcoming decisions by the fda and dsmb.
Whether bmt and the others expressing their concerns are right is left to be seen.
Hope this clears up any confusion as to my previous post..
When the "worst pr ever" was released, upon the first read i immediately knew it would trigger a selloff.....which ended up being proven 100% true.
It was made even worse when a more detailed explanation was much later provided to dales and this imo calmed many frayed nerves.
That instilled some suspicion since IMO there was no way anyone who read it wouldnt see that it was atrociously worded.....that thankfully was addressed in subsequent Prs.
Dont know about anyone else but witnessing the premarket bid/ask retreating to the 5c range was very disconcerting at first, that is until i began to view it as a potential buying opp.
All im now saying is bmt et al's concerns has once again raised my suspicions (unsubstantiated skepticism) about these missteps at this most critical of points in the process, nothing more nothing less.
I once again reiterate, his loyalty is to revive and probably to canaccord.....NOT LONGS.
Honestly speaking, why would he care if some longs get snookered into selling since there will be no shortage of investors immediately willing to snap them up.
The only event that will affect revive are the upcoming decisions by the fda and dsmb.
Whether bmt and the others expressing their concerns are right is left to be seen.
Hope this clears up any confusion as to my previous post..
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
